DAPAGLIFLOZIN: SELECTIVE SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITOR IN TYPE 2 DIABETES. Int. Res. J. Pharm. 2011;2(11):125-126. Accessed September 27, 2026. https://irjponline.org/index.php/irjp/article/view/2988